15 July 2024
Over the past five years, Roszdravnadzor has registered 35 medical products incorporating artificial intelligence (AI), 28 of which have been developed by 18 Russian innovators. Deputy Minister of Health Pavel Pugachev made this announcement during the round table discussion at the Federation Council focusing on “Legal regulation of the functioning of artificial intelligence systems in the Russian Federation: legislative development vector.”
“If at the beginning of 2019 we did not have a single registered medical product [with AI], then today we already have 35 of them, and 8 medical products were registered only in the first half of this year,” he said, adding, that these developments are used to analyze pharmacological therapy, electronic cardiograms, as well as to detect cancer and analyze electronic medical record data.
PrintOctober 10 – World Mental Health Day
10 October 2024
Long-Term Game: NovaMedica Experts at the Pharma Marketing Conference
10 October 2024
NovaMedica in the TOP-1000 Russian Managers Rating
28 September 2024
DSM Group predicts the Russian pharmaceutical market will grow by 10% annually
18 October 2024
An extra 6.1 billion rubles will be allocated for drug provision in 2025
18 October 2024
Pharmasyntez to build heparin production plant in Tatarstan
17 October 2024
17 October 2024